These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36563857)

  • 1. Neurodegeneration risk factor, EIF2AK3 (PERK), influences tau protein aggregation.
    Park G; Xu K; Chea L; Kim K; Safarta L; Song KH; Wu J; Park S; Min H; Hiramatsu N; Han J; Lin JH
    J Biol Chem; 2023 Feb; 299(2):102821. PubMed ID: 36563857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauopathy-associated PERK alleles are functional hypomorphs that increase neuronal vulnerability to ER stress.
    Yuan SH; Hiramatsu N; Liu Q; Sun XV; Lenh D; Chan P; Chiang K; Koo EH; Kao AW; Litvan I; Lin JH
    Hum Mol Genet; 2018 Nov; 27(22):3951-3963. PubMed ID: 30137327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PERK activation mitigates tau pathology
    Bruch J; Xu H; Rösler TW; De Andrade A; Kuhn PH; Lichtenthaler SF; Arzberger T; Winklhofer KF; Müller U; Höglinger GU
    EMBO Mol Med; 2017 Mar; 9(3):371-384. PubMed ID: 28148553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.
    Radford H; Moreno JA; Verity N; Halliday M; Mallucci GR
    Acta Neuropathol; 2015 Nov; 130(5):633-42. PubMed ID: 26450683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive XBP-1s-mediated activation of the endoplasmic reticulum unfolded protein response protects against pathological tau.
    Waldherr SM; Strovas TJ; Vadset TA; Liachko NF; Kraemer BC
    Nat Commun; 2019 Sep; 10(1):4443. PubMed ID: 31570707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Proteostasis in Neurodegenerative Tauopathies.
    Papanikolopoulou K; Skoulakis EMC
    Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic knock-in of EIF2AK3 variants reveals differences in PERK activity in mouse liver and pancreas under endoplasmic reticulum stress.
    Ghura S; Beratan NR; Shi X; Alvarez-Periel E; Bond Newton SE; Akay-Espinoza C; Jordan-Sciutto KL
    Sci Rep; 2024 Oct; 14(1):23812. PubMed ID: 39394239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic variation and structure-function analysis of tauopathy-associated
    Park G; Galdamez A; Song KH; Le M; Kim K; Lin JH
    medRxiv; 2024 Mar; ():. PubMed ID: 38496636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic Discovery of Neuroprotective Agents by Regulation of Tau Proteostasis via Stress-Responsive Activation of PERK Signaling.
    Shin YH; Cho H; Choi BY; Kim J; Ha J; Suh SW; Park SB
    Angew Chem Int Ed Engl; 2021 Jan; 60(4):1831-1838. PubMed ID: 33210431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis.
    Köhler C; Dinekov M; Götz J
    Neurobiol Dis; 2014 Nov; 71():169-79. PubMed ID: 25073087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cell-free screening assay for the identification of direct PERK activators.
    Costa MFD; Höglinger GU; Rösler TW
    PLoS One; 2023; 18(5):e0283943. PubMed ID: 37200357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
    Kim E; Sakata K; Liao FF
    PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
    Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
    J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
    Tang SJ; Fesharaki-Zadeh A; Takahashi H; Nies SH; Smith LM; Luo A; Chyung A; Chiasseu M; Strittmatter SM
    Acta Neuropathol Commun; 2020 Jul; 8(1):96. PubMed ID: 32611392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
    Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
    J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property.
    Liu K; Liu Y; Li L; Qin P; Iqbal J; Deng Y; Qing H
    Biochim Biophys Acta; 2016 Feb; 1862(2):192-201. PubMed ID: 26655600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and Dose-Dependent Effects of Alpha-Lipoic Acid on Human Microtubule- Associated Protein Tau-Induced Endoplasmic Reticulum Unfolded Protein Response: Implications for Alzheimer's Disease.
    Zarini-Gakiye E; Vaezi G; Parivar K; Sanadgol N
    CNS Neurol Disord Drug Targets; 2021; 20(5):451-464. PubMed ID: 33573583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.